Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × LHRH, lysine(6)-doxorubicin × Clear all

NCT01240629 2017-07-11

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms